Paul McGrane

Paul McGrane

Intellectual Property Team

Education

Montana State University
Ph.D. in Synthetic Organic Chemistry – 1992

South Dakota School of Mines & Technology
B.S. Chemistry – 1988

Consultant to Kaufhold and Dix Patent Law since 2015

Lumen Therapeutics, LLC Menlo Park, CA 2004 – 2024

Paul managed the day-to-day operation of a highly-virtual company that performed a Phase 2 clinical study testing Biologically Modified Vein Grafts in Coronary Artery Bypass (CABG). His responsibilities also included intellectual property management.

Cellgate, Inc, Sunnyvale, CA 1998 – 2004
At Cellgate, Paul assumed a lead role in development efforts for the company’s primary drug
candidate, PsorBan®, and worked with outside counsel to secure patent protection.

Roche Palo Alto, Palo Alto, CA 1996 – 1998
At Roche, Paul developed scalable processes for the manufacture of molecules of
pharmaceutical interest and transferred these processes to other Roche sites and outside
manufacturers.

Pfizer Central Research, Groton, CT 1994 – 1996
At Pfizer, Paul conceived and implemented a new and highly advantageous route to
Sorbestrin™ that was successfully scaled to pilot plant level.

Stanford University, Stanford, CA 1993 – 1994
As a Postdoctoral Research Associate, Paul played a vital role in designing and executing a
total synthesis of the chemotherapeutic agent Taxol®.

Naval Research Laboratory, Washington, DC 1987
As a Summer Intern, Paul developed methods for the formation of superconducting thin films
utilizing spray pyrolysis.

Professional Associations and Memberships
American Chemical Society since 1988
United States Patent and Trademark Office: Registered Patent Agent since 2000

Hobbies and Interests
Paul enjoys traveling with his wife for both business and pleasure, especially the 6-12 weeks per winter that they spend in Mexico. During the fall, Paul enjoys hunting pheasants, partridge, and quail with family and friends. Paul is also an inventor having 16 patents.